Decreased risk of acute gastrointestinal toxicity when substituting methotrexate with mycophenolate mofetil in the prevention of graft-versus-host disease in stem cell transplantation following myeloablative conditioning regimens

Abstract

Gastrointestinal toxicity, GvHD, hematopoietic stem cell transplantation, mycofenolate mofetil, methotrexate